InsuraGuest Technologies Inc. (TSXV:ISGI)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	1.05	1.01	0.67	0.35	0.1	0.05
Revenue Growth (YoY)	19.07%	48.98%	95.47%	252.76%	98.81%	386.72%
Cost of Revenue	0.43	0.45	0.29	0.1	0.02	0.03
Gross Profit	0.63	0.56	0.39	0.25	0.08	0.02
Selling, General & Admin	0.98	1.14	1.09	1.47	1.12	1.5
Other Operating Expenses	-	-	-0.02	-	-	-
Operating Expenses	1.05	1.2	1.12	1.64	1.58	1.52
Operating Income	-0.42	-0.64	-0.73	-1.39	-1.5	-1.5
Interest Expense	-0	-	-	-	-0	-0.01
Other Non Operating Income (Expenses)	-0.03	-0.02	-0.01	-0.02	-0.02	-0.02
EBT Excluding Unusual Items	-0.45	-0.66	-0.73	-1.41	-1.52	-1.52
Gain (Loss) on Sale of Assets	-	-	-	-	0.01	-
Other Unusual Items	-	-	0.01	-	-	-2.55
Pretax Income	-0.45	-0.66	-0.73	-1.41	-1.51	-4.07
Net Income	-0.45	-0.66	-0.73	-1.41	-1.51	-4.07
Net Income to Common	-0.45	-0.66	-0.73	-1.41	-1.51	-4.07
Shares Outstanding (Basic)	161	80	59	59	42	27
Shares Outstanding (Diluted)	161	80	59	59	42	27
Shares Change (YoY)	159.70%	34.86%	1.34%	37.95%	59.83%	79.29%
EPS (Basic)	-0.00	-0.01	-0.01	-0.02	-0.04	-0.15
EPS (Diluted)	-0.00	-0.01	-0.01	-0.02	-0.04	-0.15
Gross Margin	59.58%	55.69%	57.59%	72.12%	77.22%	40.82%
Operating Margin	-40.16%	-63.19%	-107.93%	-402.68%	-1533.15%	-3041.59%
Profit Margin	-43.16%	-65.59%	-107.58%	-408.43%	-1539.22%	-8268.80%
EBITDA	-0.41	-0.62	-0.7	-1.37	-1.48	-1.48
EBITDA Margin	-38.75%	-62.02%	-104.21%	-	-	-
D&A For EBITDA	0.01	0.01	0.03	0.03	0.02	0.02
EBIT	-0.42	-0.64	-0.73	-1.39	-1.5	-1.5
EBIT Margin	-40.16%	-63.19%	-107.93%	-	-	-
Advertising Expenses	-	0.13	0.18	0.37	0.22	0.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.